I-Thrombin engaphezulu kwe-100 idla ngokubangelwa zizifo ezahlukeneyo.

Izifo ezahlukeneyo ezifana nesifo sesibindi, isifo sezintso okanye i-systemic lupus erythematosus, njl.njl., zonke ezinokubangela ukwanda kwe-heparin-like anticoagulants emzimbeni.

Ukongeza, izifo ezahlukeneyo zesibindi zinokubangela ukwehla koxinzelelo lwe-fibrinogen, njenge-cirrhosis okanye i-hepatitis enzima, kuba amandla esibindi okuvelisa i-fibrinogen ayancipha, ngoko ke ixesha le-thrombin nalo liya kwanda.

Kucetyiswa ukuba izigulana ziye esibhedlele ukuze zihlolwe ngokweenkcukacha, kwaye emva kokuba imbangela ifunyenwe, unyango olujoliswe kulo lunokwenziwa.

I-SUCCEEDER yaseBeijing njengenye yezona mpawu ziphambili kwimarike yokuxilonga iThrombosis kunye neHemostasis eTshayina, i-SUCCEEDER inamava kumaqela e-R&D, iMveliso, iNtengiso kunye neNkonzo ezibonelela nge-coagulation analyzers kunye nee-reagents, i-blood rheology analyzers, i-ESR kunye ne-HCT analyzers, i-platelet aggregation analyzers ene-ISO13485, i-CE Certification kunye ne-FDA ezidwelisiweyo.